Document is current
Any future updates will be listed below
-
Authors
Ciniselli, C. M.
Verderio, P. https://orcid.org/0000-0002-9231-1281
Duroni, V.
Baili, P.
Pizzamiglio, S.
de Braud, F. G.
Folli, S.
Depretto, C.
Scaperrotta, G.
De Santis, M. C.
Carnevale, M. G.
De Marco, C.
Vingiani, A.
Pruneri, G.
Di Cosimo, S.
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (AIRC IG 20774)
European Commission (CAN.HEAL - 101080009)
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 11 February 2025
First Online: 9 March 2025
Declarations
:
: SDC reported fees for medical education from IQVIA; travel grants from Daiichi Sankyo; institutional grant IG 20774 from Associazione Italiana per la Ricerca sul Cancro (AIRC) and Cancer Can.Heal European EU4 Health Programme 101080009—European Commission; and serves as “ad hoc” medical advisor for Medica Scientia Innovation Research (MEDSIR), Barcelona (Spain). AV reported honoraria from Roche and Illumina. No other disclosures were reported.
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of the Fondazione IRCCS Istituto Nazionale dei Tumori—Milano (protocol code INT 196–14).
: Data are available upon reasonable request from the authors.
